FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vernon Steele

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Chemoprevention

Disorders

Concepts & Ideas

Precancerous Conditions

Physiology

Cell Divisions

Co-author Network

Publications

TOP 3
Altaf Mohammed; Misty Brewer; Naveena B Janakiram; Vernon E Steele; Krishna Vedala; Chinthalapally V Rao
Multitargeted Low-Dose GLAD Combination Chemoprevention: A Novel and Promising Approach to Combat Colon Carcinogenesis.
Ronald A Lubet; Holly L Nicastro; Vernon E Steele; Eva Szabo; Chris Tucker; Ann Bode; Stanley C Gill; Kenneth K Iwata; M Margaret Juliana; Clinton J Grubbs
Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.
Marjorie Perloff; Vernon E Steele
Early-phase development of cancer prevention agents: challenges and opportunities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vernon Steele (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Altaf Mohammed; Misty Brewer; Naveena B Janakiram; Vernon E Steele; Krishna Vedala; Chinthalapally V Rao
Multitargeted Low-Dose GLAD Combination Chemoprevention: A Novel and Promising Approach to Combat Colon Carcinogenesis.
Neoplasia (New York, N.Y.) 2013;15(5):481-90.
2013: Ronald A Lubet; Holly L Nicastro; Vernon E Steele; Eva Szabo; Chris Tucker; Ann Bode; Stanley C Gill; Kenneth K Iwata; M Margaret Juliana; Clinton J Grubbs
Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.
Cancer prevention research (Philadelphia, Pa.) 2013;6(5):448-54.
2013: Marjorie Perloff; Vernon E Steele
Early-phase development of cancer prevention agents: challenges and opportunities.
Cancer prevention research (Philadelphia, Pa.) 2013;6(5):379-83.
2012: Altaf Mohammed; Li Qian; Naveena B Janakiram; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
International journal of cancer. Journal international du cancer 2012;131(8):1951-62.
2012: Michael A Pereira; Vernon E Steele; Blake M Warner; Christopher M Weghorst; Thomas J Knobloch; Ronald A Lubet; Bruce C Casto
Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.
International journal of cancer. Journal international du cancer 2012;131(6):1277-86.
2012: Chinthalapally V Rao; Rebekah L Ritchie; Awasthi Vibhudutta; Naveena B Janakiram; Qian Li; Stan Lightfoot; Altaf Mohammed; Vernon E Steele
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
Neoplasia (New York, N.Y.) 2012;14(9):778-87.
2012: Ronald A Lubet; David L McCormick; Michael A Pereira; Vernon E Steele; W-C L Chang; Margie L Clapper; Susan M Fischer; M Margaret Juliana; Clinton J Grubbs
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
Oncology reports 2012;27(5):1400-6.
2012: Naveena B Janakiram; Altaf Mohammed; Li Qian; Chang-In Choi; Vernon E Steele; Chinthalapally V Rao
Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.
Neoplasia (New York, N.Y.) 2012;14(2):159-68.
2012: Jagan M R Patlolla; Vernon E Steele; Yuting Zhang; Qian Li; Chinthalapally V Rao
Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
International journal of oncology 2012;40(1):170-5.
2011: Altaf Mohammed; Chang-In Choi; Naveena B Janakiram; Qian Li; Vernon E Steele; Yuting Zhang; Chinthalapally V Rao
Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
Cancer prevention research (Philadelphia, Pa.) 2011;4(12):2015-26.
2011: Ronald A Lubet; Yan Lu; Ann M Bode; Ming You; Zoe M Verney; Vernon E Steele; Reid Townsend; M Margaret Juliana; Clinton J Grubbs
Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkers.
Oncology reports 2011;25(5):1389-97.
2010: Altaf Mohammed; Naveena B Janakiram; Qian Li; Venkateshwar Madka; Misty Ely; Stan Lightfoot; Howard Crawford; Vernon E Steele; Chinthalapally V Rao
The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.
Cancer prevention research (Philadelphia, Pa.) 2010;3(11):1417-26.
2010: Vernon E Steele; Ronald A Lubet
The use of animal models for cancer chemoprevention drug development.
Seminars in oncology 2010;37(4):327-38.
2010: Ronald A Lubet; Vernon E Steele; M Margaret Juliana; Clinton J Grubbs
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
The Journal of urology 2010;183(4):1598-603.
2010: Naveena B Janakiram; Altaf Mohammed; Yuting Zhang; Chang-In Choi; Carl Woodward; Peter Collin; Vernon E Steele; Chinthalapally V Rao
Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth.
Cancer prevention research (Philadelphia, Pa.) 2010;3(1):82-91.
2009: Vernon E Steele; Chinthalapally V Rao; Yuting Zhang; Jagan Patlolla; Daniel Boring; Levy Kopelovich; M Margaret Juliana; Clinton J Grubbs; Ronald A Lubet
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Cancer prevention research (Philadelphia, Pa.) 2009;2(11):951-6.
2009: Chinthalapally V Rao; Vernon E Steele; Malisetty V Swamy; Jagan M R Patlolla; Suresh Guruswamy; Levy Kopelovich
Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Cancer research 2009;69(20):8175-82.
2009: Ronald A Lubet; Daniel Boring; Vernon E Steele; J Michael Ruppert; M Margaret Juliana; Clinton J Grubbs
Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Cancer prevention research (Philadelphia, Pa.) 2009;2(2):161-7.
2008: Ronald A Lubet; Susan M Fischer; Vernon E Steele; M Margaret Juliana; Renee A Desmond; Clinton J Grubbs
Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
International journal of cancer. Journal international du cancer 2008;123(10):2254-9.
2008: Ronald A Lubet; Eva Szabo; Konstantin Christov-Tzelkov; Ann M Bode; Marna E Ericson; Vernon E Steele; M Margaret Juliana; Clinton J Grubbs
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
Molecular cancer therapeutics 2008;7(4):972-9.
2008: Fadel S Alyaqoub; Yue Liu; Lianhui Tao; Vernon E Steele; Ronald A Lubet; Michael A Pereira
Modulation by bexarotene of mRNA expression of genes in mouse lung tumors.
Molecular carcinogenesis 2008;47(3):165-71.
2007: James A Crowell; Vernon E Steele; Judith R Fay
Targeting the AKT protein kinase for cancer chemoprevention.
Molecular cancer therapeutics 2007;6(8):2139-48.
2007: Ronald A Lubet; Chung S Yang; Mao-Jung Lee; Yukihiko Hara; Izet M Kapetanovic; James A Crowell; Vernon E Steele; M Margaret Juliana; Clinton J Grubbs
Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
Molecular cancer therapeutics 2007;6(7):2022-8.
2007: Michael A Pereira; Lianhui Tao; Yue Liu; Long Li; Vernon E Steele; Ronald A Lubet
Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors.
International journal of cancer. Journal international du cancer 2007;120(5):1150-3.
2007: Kevin J Chalut; Laura Kresty; John W Pyhtila; Ronald Nines; Maureen Baird; Vernon E Steele; Adam Wax
In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(2):223-7.
2007: Fadel S Alyaqoub; Lianhui Tao; Paula M Kramer; Vernon E Steele; Ronald A Lubet; William Gunning; Michael A Pereira
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT).
Carcinogenesis 2007;28(1):124-9.
2006: Fadel S Alyaqoub; Lianhui Tao; Paula M Kramer; Vernon E Steele; Ronald A Lubet; William Gunning; Michael A Pereira
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT).
Carcinogenesis 2006;27(12):2442-7.
2006: Michael A Pereira; Paula M Kramer; Ronald Nines; Yue Liu; Fadel S Alyaqoub; William Gunning; Vernon E Steele; Ronald A Lubet
Prevention of mouse lung tumors by targretin.
International journal of cancer. Journal international du cancer 2006;118(9):2359-62.
2006: Ronald A Lubet; Konstantin Christov-Tzelkov; Ming You; Ruisheng Yao; Vernon E Steele; David W End; M Margaret Juliana; Clinton J Grubbs
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations.
Molecular cancer therapeutics 2006;5(4):1073-8.
2005: Adam Wax; John W Pyhtila; Robert N Graf; Ronald Nines; Charles W Boone; Ramachandra R Dasari; Michael S Feld; Vernon E Steele; Gary D Stoner
Prospective grading of neoplastic change in rat esophagus epithelium using angle-resolved low-coherence interferometry.
Journal of biomedical optics 2005;10(5):051604.
2005: Keith Crist; Zhongqiu Zhang; Ming You; William Gunning; Phillip B Conran; Vernon E Steele; Ronald A Lubet
Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture.
Carcinogenesis 2005;26(5):951-7.
2005: Ronald A Lubet; Kay Huebner; Louise Y Y Fong; Dario C Altieri; Vernon E Steele; Levy Kopelovich; Claudine Kavanaugh; M Margaret Juliana; Seng-Jaw Soong; Clinton J Grubbs
4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Carcinogenesis 2005;26(3):571-8.
2005: Ronald A Lubet; Konstantin Christov-Tzelkov; Nomeli P Nunez; Stephen D Hursting; Vernon E Steele; M Margaret Juliana; Isao Eto; Clinton J Grubbs
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
Carcinogenesis 2005;26(2):441-8.
2004: Michael A Pereira; Lianhui Tao; Wei Wang; Yingzhe Li; Asad Umar; Vernon E Steele; Ronald A Lubet
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors.
Carcinogenesis 2004;25(10):1917-23.
2004: Lianhui Tao; Wei Wang; Paula M Kramer; Ronald A Lubet; Vernon E Steele; Michael A Pereira
Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer.
Molecular carcinogenesis 2004;39(2):79-84.
2004: Mark B Cope; Vernon E Steele; Ronald A Lubet; Isao Eto; M Margaret Juliana; Donald L Hill; Clinton J Grubbs
Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
Oncology reports 2004;11(2):465-9.
2003: Haiming Ding; Chunhua Han; Ruth Gibson-D'Ambrosio; Vernon E Steele; Steven M D'Ambrosio
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
International journal of cancer. Journal international du cancer 2003;107(5):830-6.
2003: James A Crowell; Vernon E Steele; Caroline C Sigman; Judith R Fay
Is inducible nitric oxide synthase a target for chemoprevention?
Molecular cancer therapeutics 2003;2(8):815-23.
2003: Adam Wax; Changhuei Yang; Markus G Müller; Ronald Nines; Charles W Boone; Vernon E Steele; Gary D Stoner; Ramachandra R Dasari; Michael S Feld
In situ detection of neoplastic transformation and chemopreventive effects in rat esophagus epithelium using angle-resolved low-coherence interferometry.
Cancer research 2003;63(13):3556-9.
2003: William Gunning; Paula M Kramer; Ronald A Lubet; Vernon E Steele; David W End; Walter Wouters; Michael A Pereira
Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1927-30.
2003: Vernon E Steele; Ernest T Hawk; Jaye L Viner; Ronald A Lubet
Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.
Mutation research 2003;523-524():137-44.
2003: Vernon E Steele
Current mechanistic approaches to the chemoprevention of cancer.
Journal of biochemistry and molecular biology 2003;36(1):78-81.
2002: Vernon E Steele; Charles W Boone; Daniel Dauzonne; Chinthalapally V Rao; René V Bensasson
Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon.
Cancer research 2002;62(22):6506-9.
2002: Lianhui Tao; Yingzhe Li; Wei Wang; Paula M Kramer; William Gunning; Ronald A Lubet; Vernon E Steele; Michael A Pereira
Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
Molecular carcinogenesis 2002;35(2):93-102.
2002: Lianhui Tao; Paula M Kramer; Wei Wang; Siming Yang; Ronald A Lubet; Vernon E Steele; Michael A Pereira
Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents.
Carcinogenesis 2002;23(9):1447-54.
2002: William Gunning; Paula M Kramer; Vernon E Steele; Michael A Pereira
Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice.
Cancer research 2002;62(15):4199-201.
2002: Michael A Pereira; Yingzhe Li; William Gunning; Paula M Kramer; Fadel Al-Yaqoub; Ronald A Lubet; Vernon E Steele; Eva Szabo; Lianhui Tao
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.
Carcinogenesis 2002;23(7):1185-92.
2002: Mark B Cope; Vernon E Steele; Isao Eto; M Margaret Juliana; Donald L Hill; Clinton J Grubbs
Prevention of methylnitrosourea-induced mammary cancers by 9-cis-retinoic acid and/or vitamin D3.
Oncology reports 2002;9(3):533-7.
2002: Cristina Rodríguez-Burford; Vernon E Steele; Amy S Anderson; Cecil R Stockard; Heidi L Weiss; Isao Eto; Gary L Johanning; William E Grizzle; Clinton J Grubbs
Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
Nutrition and cancer 2002;43(1):67-75.
2001: Steven M D'Ambrosio; Ruth Gibson-D'Ambrosio; Gulzar Wani; Bruce C Casto; GE Milo; Gary J Kelloff; Vernon E Steele
Modulation of Ki67, p53 and RARbeta expression in normal, premalignant and malignant human oral epithelial cells by chemopreventive agents.
Anticancer research 2001;21(5):3229-35.
2001: Ashok Gupta; Ronald Nines; Kapila A Rodrigo; R A Aziz; Peter S Carlton; D L Gray; Vernon E Steele; Mark A Morse; Gary D Stoner
Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat.
Journal of the National Cancer Institute 2001;93(13):990-8.
2001: Gary J Kelloff; Ronald Lieberman; Vernon E Steele; Charles W Boone; Ronald A Lubet; Levy Kopelovich; WA Malone; James A Crowell; H R Higley; Caroline C Sigman
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
Urology 2001;57(4 Suppl 1):46-51.
2001: Cristina Rodríguez-Burford; Ronald A Lubet; Vernon E Steele; Isao Eto; M Bandy; M Margaret Juliana; Heidi L Weiss; William E Grizzle; Gary J Kelloff; Clinton J Grubbs
Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.
Oncology reports 2001;8(2):373-9.
2000: William Gunning; Paula M Kramer; Ronald A Lubet; Vernon E Steele; Michael A Pereira
Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice.
Experimental lung research 2000;26(8):757-72.
2000: Clinton J Grubbs; Ronald A Lubet; Alane T Koki; Kathleen M Leahy; Jaime L Masferrer; Vernon E Steele; Gary J Kelloff; Donald L Hill; Karen Seibert
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Cancer research 2000;60(20):5599-602.
2000: Vernon E Steele; CA Holmes; Ernest T Hawk; Levy Kopelovich; Ronald A Lubet; James A Crowell; Caroline C Sigman; Gary J Kelloff
Potential use of lipoxygenase inhibitors for cancer chemoprevention.
Expert opinion on investigational drugs 2000;9(9):2121-38.
2000: Steven M D'Ambrosio; Ruth Gibson-D'Ambrosio; GE Milo; Bruce C Casto; Gary J Kelloff; Vernon E Steele
Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents.
Anticancer research 2000;20(4):2273-80.
2000: Gary J Kelloff; James A Crowell; Vernon E Steele; Ronald A Lubet; WA Malone; Charles W Boone; Levy Kopelovich; Ernest T Hawk; Ronald Lieberman; JA Lawrence; I Ali; Jaye L Viner; Caroline C Sigman
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.
The Journal of nutrition 2000;130(2S Suppl):467S-471S.
2000: Vernon E Steele; Gary J Kelloff; DA Balentine; Charles W Boone; Rajendra Mehta; D Bagheri; Caroline C Sigman; S Zhu; Sheela Sharma
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays.
Carcinogenesis 2000;21(1):63-7.
1999: H Li; Paula M Kramer; Ronald A Lubet; Vernon E Steele; Gary J Kelloff; Michael A Pereira
Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
Cancer letters 1999;147(1-2):187-93.
1999: Vernon E Steele; CA Holmes; Ernest T Hawk; Levy Kopelovich; Ronald A Lubet; James A Crowell; Caroline C Sigman; Gary J Kelloff
Lipoxygenase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(5):467-83.
1999: Vernon E Steele; D Bagheri; DA Balentine; Charles W Boone; Rajendra Mehta; Mark A Morse; Sheela Sharma; Caroline C Sigman; Gary D Stoner; Michael J Wargovich; John H Weisburger; S Zhu; Gary J Kelloff
Preclinical efficacy studies of green and black tea extracts.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1999;220(4):210-2.
1999: H Li; Herman A J Schut; Phillip B Conran; Paula M Kramer; Ronald A Lubet; Vernon E Steele; E E Hawk; Gary J Kelloff; Michael A Pereira
Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
Carcinogenesis 1999;20(3):425-30.
1999: Y Zheng; Paula M Kramer; Ronald A Lubet; Vernon E Steele; Gary J Kelloff; Michael A Pereira
Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
Carcinogenesis 1999;20(2):255-60.
1999: Gary J Kelloff; James A Crowell; Vernon E Steele; Ronald A Lubet; Charles W Boone; WA Malone; Ernest T Hawk; Ronald Lieberman; JA Lawrence; Levy Kopelovich; I Ali; Jaye L Viner; Caroline C Sigman
Progress in cancer chemoprevention.
Annals of the New York Academy of Sciences 1999;889():1-13.
1999: Gary J Kelloff; Ronald Lieberman; Vernon E Steele; Charles W Boone; Ronald A Lubet; L Kopelovitch; WA Malone; James A Crowell; Caroline C Sigman
Chemoprevention of prostate cancer: concepts and strategies.
European urology 1999;35(5-6):342-50.
1999: Cristina Rodríguez-Burford; Ronald A Lubet; Isao Eto; M Margaret Juliana; Gary J Kelloff; Clinton J Grubbs; Vernon E Steele
Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
Carcinogenesis 1999;20(1):71-6.
1998: Vernon E Steele; Charles W Boone; Ronald A Lubet; James A Crowell; CA Holmes; Caroline C Sigman; Gary J Kelloff
Preclinical drug development paradigms for chemopreventives.
Hematology/oncology clinics of North America 1998;12(5):943-61, v-vi.
1998: R Parshad; KK Sanford; FM Price; Vernon E Steele; Robert E Tarone; Gary J Kelloff; Charles W Boone
Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells.
Anticancer research 1998;18(5A):3263-6.
1998: Ronald A Lubet; Vernon E Steele; R DeCoster; C Bowden; Ming You; M Margaret Juliana; Isao Eto; Gary J Kelloff; Clinton J Grubbs
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Carcinogenesis 1998;19(8):1345-51.
1998: Charles W Boone; Vernon E Steele; D Gaylor; Gary J Kelloff
Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitor.
Mutation research 1998;402(1-2):173-7.
1998: Ronald A Lubet; Gary B Gordon; Russell A Prough; X D Lei; Ming You; Yunfei Wang; Clinton J Grubbs; Vernon E Steele; Gary J Kelloff; C F Thomas; R D Moon
Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Cancer research 1998;58(5):921-6.
1998: C Clifford Conaway; D Jiao; Gary J Kelloff; Vernon E Steele; Abraham Rivenson; Fung-Lung Chung
Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco-nitrosamine-induced lung tumors in A/J mice.
Cancer letters 1998;124(1):85-93.
1998: H Li; Paula M Kramer; Ronald A Lubet; Vernon E Steele; Gary J Kelloff; Michael A Pereira
Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats.
Cancer letters 1998;124(1):39-46.
1998: Gary J Kelloff; Ronald A Lubet; Ronald Lieberman; K Eisenhauer; Vernon E Steele; James A Crowell; Ernest T Hawk; Charles W Boone; Caroline C Sigman
Aromatase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(1):65-78.
1998: John H Weisburger; Abraham Rivenson; Cesar Aliaga; Joel Reinhardt; Gary J Kelloff; Charles W Boone; Vernon E Steele; DA Balentine; Brian Pittman; Edith Zang
Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1998;217(1):104-8.
1997: Y Zheng; Paula M Kramer; G Olson; Ronald A Lubet; Vernon E Steele; Gary J Kelloff; Michael A Pereira
Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.
Carcinogenesis 1997;18(11):2119-25.
1997: Charles W Boone; James Bacus; James Bacus; Vernon E Steele; Gary J Kelloff
Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1997;216(2):151-65.
1997: Ronald A Lubet; Vernon E Steele; Isao Eto; M Margaret Juliana; Gary J Kelloff; Clinton J Grubbs
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model.
International journal of cancer. Journal international du cancer 1997;72(1):95-101.
1997: Gary J Kelloff; Ronald A Lubet; Judith R Fay; Vernon E Steele; Charles W Boone; James A Crowell; Caroline C Sigman
Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):267-82.
1997: Keith Crist; Yian Wang; Ronald A Lubet; Vernon E Steele; Gary J Kelloff; Ming You
Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.
Journal of cellular biochemistry. Supplement 1997;27():92-9.
1997: L Hu; L Lin; Keith Crist; Gary J Kelloff; Vernon E Steele; Ronald A Lubet; Ming You; Yian Wang
Detection of differentially expressed genes in methylnitrosourea-induced rat mammary adenocarcinomas.
Journal of cellular biochemistry. Supplement 1997;28-29():117-24.
1997: Charles W Boone; James Bacus; James Bacus; Vernon E Steele; Gary J Kelloff
Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Journal of cellular biochemistry. Supplement 1997;28-29():1-20.
1997: Mark A Morse; Laura Kresty; Vernon E Steele; Gary J Kelloff; Charles W Boone; DA Balentine; ME Harbowy; Gary D Stoner
Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis.
Nutrition and cancer 1997;29(1):7-12.
1997: Gary J Kelloff; Charles W Boone; James A Crowell; S G Nayfield; Ernest T Hawk; Vernon E Steele; Ronald A Lubet; Caroline C Sigman
Perspectives and progress in development of breast cancer chemopreventive drugs.
Progress in clinical and biological research 1997;396():159-83.